+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Multiomics Market Outlook 2026-2034: by Product (Instruments, Reagents, Other Products), Platform, Application, End User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6242562
UP TO OFF until Jan 01st 2027
The Multiomics Market is estimated at US$5.1 billion in 2026 and is projected to grow at a CAGR of 15.3% to reach US$15.9 billion by 2034.

Market Overview

The Multiomics Market covers research and analytical approaches that combine genomics, transcriptomics, proteomics, metabolomics, and related data to create deeper biological understanding.

Relevant uses and settings include drug discovery, biomarker research, precision medicine, academic biology, translational studies, and systems level disease investigation. Commercial considerations include data complexity, high analysis cost, workflow integration burdens, and requirement for advanced informatics and interpretation expertise across large studies.

Market Segmentation

By Product

  • Instruments
  • Reagents
  • Other Products

By Platform

  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms
  • Other Platforms

By Application

  • Cell Biology
  • Oncology
  • Neurology
  • Immunology
  • Other Applications

By End User

  • Academic and Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Key Companies Analysed

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • QIAGEN
  • Danaher
  • Bio-Rad Laboratories
  • Bruker
  • Waters Corporation
  • Standard BioTools
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Genomics
  • 10x Genomics
  • Roche
  • Revvity
  • Merck KGaA
  • Shimadzu
  • SomaLogic
  • Seer
  • NanoString Technologies

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Multiomics Market Overview
2.1. Multiomics Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Multiomics Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Multiomics Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Multiomics Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Multiomics Market Analysis By Product, 2025-2034
5.2.1. Instruments
5.2.2. Reagents
5.2.3. Other Products
5.3. Multiomics Market Analysis By Platform, 2025-2034
5.3.1. Genomics
5.3.2. Transcriptomics
5.3.3. Proteomics
5.3.4. Metabolomics
5.3.5. Integrated Omics Platforms
5.3.6. Other Platforms
5.4. Multiomics Market Analysis By Application, 2025-2034
5.4.1. Cell Biology
5.4.2. Oncology
5.4.3. Neurology
5.4.4. Immunology
5.4.5. Other Applications
5.5. Multiomics Market Analysis By End User, 2025-2034
5.5.1. Academic and Research Institutes
5.5.2. Pharmaceutical & Biotechnology Companies
5.5.3. Other End Users
6. North America Multiomics Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Multiomics Market Analysis By Product
6.3. North America Multiomics Market Analysis By Platform
6.4. North America Multiomics Market Analysis By Application
6.5. North America Multiomics Market Analysis By End User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Multiomics Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Multiomics Market Analysis By Product
7.3. Europe Multiomics Market Analysis By Platform
7.4. Europe Multiomics Market Analysis By Application
7.5. Europe Multiomics Market Analysis By End User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Multiomics Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Multiomics Market Analysis By Product
8.3. Asia-Pacific Multiomics Market Analysis By Platform
8.4. Asia-Pacific Multiomics Market Analysis By Application
8.5. Asia-Pacific Multiomics Market Analysis By End User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Multiomics Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Multiomics Market Analysis By Product
9.3. Middle East and Africa Multiomics Market Analysis By Platform
9.4. Middle East and Africa Multiomics Market Analysis By Application
9.5. Middle East and Africa Multiomics Market Analysis By End User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Multiomics Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Multiomics Market Analysis By Product
10.3. South and Central America Multiomics Market Analysis By Platform
10.4. South and Central America Multiomics Market Analysis By Application
10.5. South and Central America Multiomics Market Analysis By End User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Multiomics Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Illumina
11.2.2. Thermo Fisher Scientific
11.2.3. Agilent Technologies
11.2.4. QIAGEN
11.2.5. Danaher
11.2.6. Bio-Rad Laboratories
11.2.7. Bruker
11.2.8. Waters Corporation
11.2.9. Standard BioTools
11.2.10. Pacific Biosciences
11.2.11. Oxford Nanopore Technologies
11.2.12. BGI Genomics
11.2.13. 10x Genomics
11.2.14. Roche
11.2.15. Revvity
11.2.16. Merck KGaA
11.2.17. Shimadzu
11.2.18. SomaLogic
11.2.19. Seer
11.2.20. NanoString Technologies
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • QIAGEN
  • Danaher
  • Bio-Rad Laboratories
  • Bruker
  • Waters Corporation
  • Standard BioTools
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Genomics
  • 10x Genomics
  • Roche
  • Revvity
  • Merck KGaA
  • Shimadzu
  • SomaLogic
  • Seer
  • NanoString Technologies

Table Information